Bisoprolol--comparative toxicokinetic study after oral and conjunctival administration in beagles.

Lens and eye toxicity research Pub Date : 1990-01-01
K U Bühring, A Metallinos, N Jakobs, F von Landenberg, E Merck
{"title":"Bisoprolol--comparative toxicokinetic study after oral and conjunctival administration in beagles.","authors":"K U Bühring,&nbsp;A Metallinos,&nbsp;N Jakobs,&nbsp;F von Landenberg,&nbsp;E Merck","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Beagles were treated with bisoprolol, a beta 1-selective adrenoceptor antagonist, for 30 days with the following daily doses: oral: 30 mg/kg; conjunctival: 0.5% solution (approx. 0.04 mg/kg) and 5% solution (approx. 0.4 mg/kg). Drug concentrations were determined in plasma and various eye tissues on days 1, 16, and 30, and on day 59, i.e. on day 29 of the follow-up period. Bisoprolol concentrations in plasma and most eye tissues were considerably higher after oral than after conjunctival treatment. The highest tissue concentrations were observed in the iris (+ciliary body) and retina (+choroid) with tissue/plasma concentration ratios between 100 and 150 after oral and 1000 to 3000 after conjunctival instillation (5% solution). In plasma no accumulation of the drug was observed which is in accordance with its plasma half-life of 4 to 5 h. In contrast to this, concentrations in the iris and retina increased from day 1 to day 16 and 30 by 3 to 8 times and the half-life of bisoprolol in these tissues was estimated to be between 3 to 5 days.</p>","PeriodicalId":17964,"journal":{"name":"Lens and eye toxicity research","volume":"7 3-4","pages":"335-45"},"PeriodicalIF":0.0000,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lens and eye toxicity research","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Beagles were treated with bisoprolol, a beta 1-selective adrenoceptor antagonist, for 30 days with the following daily doses: oral: 30 mg/kg; conjunctival: 0.5% solution (approx. 0.04 mg/kg) and 5% solution (approx. 0.4 mg/kg). Drug concentrations were determined in plasma and various eye tissues on days 1, 16, and 30, and on day 59, i.e. on day 29 of the follow-up period. Bisoprolol concentrations in plasma and most eye tissues were considerably higher after oral than after conjunctival treatment. The highest tissue concentrations were observed in the iris (+ciliary body) and retina (+choroid) with tissue/plasma concentration ratios between 100 and 150 after oral and 1000 to 3000 after conjunctival instillation (5% solution). In plasma no accumulation of the drug was observed which is in accordance with its plasma half-life of 4 to 5 h. In contrast to this, concentrations in the iris and retina increased from day 1 to day 16 and 30 by 3 to 8 times and the half-life of bisoprolol in these tissues was estimated to be between 3 to 5 days.

比索洛尔——小猎犬口服和结膜给药后的比较毒性动力学研究。
比格尔是一种β 1选择性肾上腺素能受体拮抗剂,用比索洛尔治疗比格尔30天,每日剂量如下:口服:30 mg/kg;结膜:0.5%溶液(约。0.04 mg/kg)和5%溶液(约0.04 mg/kg)。0.4毫克/公斤)。在随访第1、16、30天和第59天,即第29天,测定血浆和各眼组织中的药物浓度。口服比索洛尔后血浆和大多数眼组织浓度明显高于结膜治疗后的浓度。虹膜(+睫状体)和视网膜(+脉络膜)组织浓度最高,口服后组织/血浆浓度比为100 ~ 150,结膜灌注后组织/血浆浓度比为1000 ~ 3000(5%溶液)。在血浆中没有观察到药物的积累,这符合其血浆半衰期为4至5小时。与此相反,虹膜和视网膜中的浓度从第1天到第16天和第30天增加了3至8倍,比索洛尔在这些组织中的半衰期估计在3至5天之间。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信